These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma. Tomaselli S; Galeano F; Alon S; Raho S; Galardi S; Polito VA; Presutti C; Vincenti S; Eisenberg E; Locatelli F; Gallo A Genome Biol; 2015 Jan; 16(1):5. PubMed ID: 25582055 [TBL] [Abstract][Full Text] [Related]
3. A-to-I editing in human miRNAs is enriched in seed sequence, influenced by sequence contexts and significantly hypoedited in glioblastoma multiforme. Paul D; Sinha AN; Ray A; Lal M; Nayak S; Sharma A; Mehani B; Mukherjee D; Laddha SV; Suri A; Sarkar C; Mukhopadhyay A Sci Rep; 2017 May; 7(1):2466. PubMed ID: 28550310 [TBL] [Abstract][Full Text] [Related]
4. Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells. Choudhury Y; Tay FC; Lam DH; Sandanaraj E; Tang C; Ang BT; Wang S J Clin Invest; 2012 Nov; 122(11):4059-76. PubMed ID: 23093778 [TBL] [Abstract][Full Text] [Related]
5. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma. Oakes E; Anderson A; Cohen-Gadol A; Hundley HA J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531 [TBL] [Abstract][Full Text] [Related]
6. ADAR1- and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism. Widmark A; Sagredo EA; Karlström V; Behm M; Biryukova I; Friedländer MR; Daniel C; Öhman M J Biol Chem; 2022 Mar; 298(3):101682. PubMed ID: 35124003 [TBL] [Abstract][Full Text] [Related]
7. Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients. Shahar T; Granit A; Zrihan D; Canello T; Charbit H; Einstein O; Rozovski U; Elgavish S; Ram Z; Siegal T; Lavon I J Neurooncol; 2016 Dec; 130(3):413-422. PubMed ID: 27573219 [TBL] [Abstract][Full Text] [Related]
8. Anti-tumoral effects of miR-3189-3p in glioblastoma. Jeansonne D; DeLuca M; Marrero L; Lassak A; Pacifici M; Wyczechowska D; Wilk A; Reiss K; Peruzzi F J Biol Chem; 2015 Mar; 290(13):8067-80. PubMed ID: 25645911 [TBL] [Abstract][Full Text] [Related]
9. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Kawahara Y; Zinshteyn B; Sethupathy P; Iizasa H; Hatzigeorgiou AG; Nishikura K Science; 2007 Feb; 315(5815):1137-40. PubMed ID: 17322061 [TBL] [Abstract][Full Text] [Related]
10. Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion. Sun J; Tian X; Zhang J; Huang Y; Lin X; Chen L; Zhang S J Exp Clin Cancer Res; 2017 Aug; 36(1):100. PubMed ID: 28764788 [TBL] [Abstract][Full Text] [Related]
11. ADAR2 induces reproducible changes in sequence and abundance of mature microRNAs in the mouse brain. Vesely C; Tauber S; Sedlazeck FJ; Tajaddod M; von Haeseler A; Jantsch MF Nucleic Acids Res; 2014 Oct; 42(19):12155-68. PubMed ID: 25260591 [TBL] [Abstract][Full Text] [Related]
12. Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma. Silvestris DA; Picardi E; Cesarini V; Fosso B; Mangraviti N; Massimi L; Martini M; Pesole G; Locatelli F; Gallo A Genome Biol; 2019 Feb; 20(1):33. PubMed ID: 30760294 [TBL] [Abstract][Full Text] [Related]
13. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma. Cheng ZX; Song YX; Wang ZY; Wang Y; Dong Y Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4079-4086. PubMed ID: 29028093 [TBL] [Abstract][Full Text] [Related]
14. miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells. Li XT; Wang HZ; Wu ZW; Yang TQ; Zhao ZH; Chen GL; Xie XS; Li B; Wei YX; Huang YL; Zhou YX; Du ZW Cell Mol Neurobiol; 2015 Jul; 35(5):679-87. PubMed ID: 25662849 [TBL] [Abstract][Full Text] [Related]
16. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers. Wang Y; Xu X; Yu S; Jeong KJ; Zhou Z; Han L; Tsang YH; Li J; Chen H; Mangala LS; Yuan Y; Eterovic AK; Lu Y; Sood AK; Scott KL; Mills GB; Liang H Genome Res; 2017 Jul; 27(7):1112-1125. PubMed ID: 28411194 [TBL] [Abstract][Full Text] [Related]
17. Abnormal expression of an ADAR2 alternative splicing variant in gliomas downregulates adenosine-to-inosine RNA editing. Wei J; Li Z; Du C; Qi B; Zhao X; Wang L; Bi L; Wang G; Zhang X; Su X; Pan Y; Tian Y Acta Neurochir (Wien); 2014 Jun; 156(6):1135-42. PubMed ID: 24509948 [TBL] [Abstract][Full Text] [Related]
18. Frequency and fate of microRNA editing in human brain. Kawahara Y; Megraw M; Kreider E; Iizasa H; Valente L; Hatzigeorgiou AG; Nishikura K Nucleic Acids Res; 2008 Sep; 36(16):5270-80. PubMed ID: 18684997 [TBL] [Abstract][Full Text] [Related]
19. RNA editing enzyme ADAR2 regulates P-glycoprotein expression in murine breast cancer cells through the circRNA-miRNA pathway. Omata Y; Haraguchi M; Yoshinaga S; Ogino T; Okawa M; Tsuruta A; Koyanagi S; Ohdo S Biochem Biophys Res Commun; 2024 Sep; 726():150289. PubMed ID: 38917633 [TBL] [Abstract][Full Text] [Related]
20. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Gao X; Jin W Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]